Medicare Enrolled

Dr. Ricardo Aleman Chinea, M.D

Family Medicine · Loxahatchee, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
12955 PALMS WEST DR, Loxahatchee, FL 33470
5613335022
In practice since 2010 (15 years)
NPI: 1104132927 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aleman Chinea from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aleman Chinea? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aleman Chinea

Dr. Ricardo Aleman Chinea is a family medicine in Loxahatchee, FL, with 15 years in practice. Based on federal Medicare data, Dr. Aleman Chinea performed 961 Medicare services across 669 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aleman Chinea received a total of $12,659 from 55 pharmaceutical and/or device companies across 688 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aleman Chinea is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ Top 36% volume in FL$ $12,659 industry payments

Medicare Practice Summary

Medicare Utilization ↗
961
Medicare services
Top 36% in FL for family medicine
669
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~64 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)354$66$239
Blood draw (venipuncture)138$8$15
Annual wellness visit, follow-up125$130$344
Annual depression screening124$18$48
Urinalysis, manual113$3$9
Office visit, established patient (30-39 min)59$91$339
New patient office visit (30-44 min)22$86$296
Electrocardiogram (EKG), 12-lead13$10$39
Transitional care management services for problem of at least moderate complexity13$165$533
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,659
Total received (2018-2024)
Avg $1,808/year across 7 years
Top 3% in FL for family medicine
55
Companies
688
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,659 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,830
2023
$2,572
2022
$1,867
2021
$2,056
2020
$1,395
2019
$1,415
2018
$1,526

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,944
Novo Nordisk Inc
$1,396
PFIZER INC.
$1,349
Lilly USA, LLC
$1,220
AbbVie Inc.
$863
GlaxoSmithKline, LLC.
$842
Amarin Pharma Inc.
$393
ABBVIE INC.
$383
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$375
Takeda Pharmaceuticals U.S.A., Inc.
$310
Merck Sharp & Dohme Corporation
$294
Currax Pharmaceuticals LLC
$256
Amgen Inc.
$237
Bayer HealthCare Pharmaceuticals Inc.
$235
Allergan, Inc.
$227
Boehringer Ingelheim Pharmaceuticals, Inc.
$197
KVK-Tech, Inc.
$195
Abbott Laboratories
$190
Biohaven Pharmaceutical Holding Company Ltd.
$185
Exact Sciences Corporation
$140
IDORSIA PHARMACEUTICALS US INC
$117
Esperion Therapeutics, Inc.
$114
Kowa Pharmaceuticals America, Inc.
$108
Bayer Healthcare Pharmaceuticals Inc.
$101
Eisai Inc.
$72
Novartis Pharmaceuticals Corporation
$72
Janssen Pharmaceuticals, Inc
$63
Phathom Pharmaceuticals, Inc.
$59
Alvogen Inc
$56
ARBOR PHARMACEUTICALS, INC.
$47
Almatica Pharma LLC
$47
Nevro Corp.
$42
Synergy Pharmaceuticals Inc
$41
Adlon Therapeutics L.P.
$38
Biohaven Pharmaceuticals, Inc.
$37
Medtronic, Inc.
$35
Merck Sharp & Dohme LLC
$33
Endo Pharmaceuticals Inc.
$30
Allergan Inc.
$29
Astellas Pharma US Inc
$26
Ironshore Pharmaceuticals Inc.
$24
Shield Therapeutics Inc
$23
Ferring Pharmaceuticals Inc.
$23
FIDIA PHARMA USA INC.
$23
Horizon Therapeutics plc
$22
Incyte Corporation
$19
AbbVie, Inc.
$17
SANOFI-AVENTIS U.S. LLC
$17
Genentech USA, Inc.
$17
Hologic, LLC
$16
Teva Pharmaceuticals USA, Inc.
$15
Dexcom, Inc.
$15
Shire North American Group Inc
$15
Neurocrine Biosciences, Inc.
$13
Cardiovascular Systems Inc.
$6
Top 3 companies account for 37.0% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADHANSIA XR · AIRSUPRA · ANORO · AUSTEDO · Aimovig · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CHANTIX · COMIRNATY · CONTRAVE · Cologuard Collection Kit · DUEXIS · Dayvigo · Dexcom G6 Transmitter · Diamondback Peripheral · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · Edarbi · Edarbyclor · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · Humira · Hymovis · INGREZZA · INVOKANA · JANUVIA · JARDIANCE · JETI ALL IN ONE NON-STERILE KIT · Jornay PM 20mg capsules (Bottle of 100) · KYPHON EXPRESS II KYPHOPAK TRAY · Kerendia · LEQVIO · LINZESS · LOREEV XR · LYRICA · Livalo · MOUNJARO · NASCOBAL · NEXLETOL · NURTEC ODT · ONZETRA XSAIL · OPZELURA · Omnia · Otezla · Ozempic · PAXLOVID · PREMARIN · PREVNAR 20 · QULIPTA · QUVIVIQ · REBYOTA · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TERIPARATIDE · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Thinprep · Tresiba · Trintellix · Trulance · UBRELVY · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XIFAXAN · Xofluza · Xultophy 100/3.6 · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in FL.

Equivalent to $1,317 per 100 Medicare services performed
Looking for a family medicine in Loxahatchee?
Compare family medicines in the Loxahatchee area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
327
Per 100K population
21.7
County median income
$81,115
Nearest hospital
HCA FLORIDA PALMS WEST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Aleman Chinea is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 3%), with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Aleman Chinea experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Aleman Chinea performed 354 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aleman Chinea receive payments from pharmaceutical companies?
Yes. Dr. Aleman Chinea received a total of $12,659 from 55 companies across 688 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aleman Chinea's costs compare to other family medicines in Loxahatchee?
Dr. Aleman Chinea's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aleman Chinea) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →